These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32020719)

  • 1. Postburn leukoderma successfully treated with topical daylight psoralen UVA therapy.
    Alzahrani Z; Ghobara YA; AlJasser MI
    Dermatol Ther; 2020 Mar; 33(2):e13248. PubMed ID: 32020719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsurgical Treatment of Postburn Hypopigmentation: A Literature Review.
    Lupon E; Berkane Y; Bertheuil N; Cetrulo CL; Vaillant C; Chaput B; Camuzard O; Lellouch AG
    J Burn Care Res; 2024 May; 45(3):601-607. PubMed ID: 38401148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of psoralen therapies obtained abroad in two children with Vitiligo.
    Bell KA; Saardi KM; Norton SA; Habeshian KA
    Pediatr Dermatol; 2020 Sep; 37(5):922-924. PubMed ID: 32749013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case of leukoderma punctata after topical PUVA treatment.
    Park JH; Lee MH
    Int J Dermatol; 2004 Feb; 43(2):138-9. PubMed ID: 15125506
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitiligo: a retrospective comparative analysis of treatment modalities in 500 patients.
    Handa S; Pandhi R; Kaur I
    J Dermatol; 2001 Sep; 28(9):461-6. PubMed ID: 11603385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study.
    Ermis O; Alpsoy E; Cetin L; Yilmaz E
    Br J Dermatol; 2001 Sep; 145(3):472-5. PubMed ID: 11531839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
    Lee Y; Seo YJ; Lee JH; Park JK
    Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study.
    Kwok YK; Anstey AV; Hawk JL
    Clin Exp Dermatol; 2002 Mar; 27(2):104-10. PubMed ID: 11952699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Science and (Lost) Art of Psoralen Plus UVA Phototherapy.
    Richard EG
    Dermatol Clin; 2020 Jan; 38(1):11-23. PubMed ID: 31753184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy.
    Aggarwal K; Khandpur S; Khanna N; Sharma VK; Pandav CS
    Int J Dermatol; 2013 Apr; 52(4):478-85. PubMed ID: 23431966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches.
    Parsad D; Pandhi R; Dogra S; Kumar B
    J Am Acad Dermatol; 2004 Jan; 50(1):63-7. PubMed ID: 14699367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new psoralen-containing gel for topical PUVA therapy: development, and treatment results in patients with palmoplantar and plaque-type psoriasis, and hyperkeratotic eczema.
    De Rie MA; Van Eendenburg JP; Versnick AC; Stolk LM; Bos JD; Westerhof W
    Br J Dermatol; 1995 Jun; 132(6):964-9. PubMed ID: 7662576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcipotriol and PUVA as treatment for vitiligo.
    Cherif F; Azaiz MI; Ben Hamida A; Ben O; Dhari A
    Dermatol Online J; 2003 Dec; 9(5):4. PubMed ID: 14996377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of vitiligo. Results of a questionnaire among dermatologists in The Netherlands.
    Njoo MD; Bossuyt PM; Westerhof W
    Int J Dermatol; 1999 Nov; 38(11):866-72. PubMed ID: 10583624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukoderma punctatum following systemic PUVA therapy.
    Dogra S; Jain R; Parsad D; Handa S
    Int J Dermatol; 2002 Dec; 41(12):922-3. PubMed ID: 12492990
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukoderma punctata following topical PUVAsol treatment.
    Fernandes NC; Pina JC
    An Bras Dermatol; 2010; 85(4):571-2. PubMed ID: 20944925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.